Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope

NCT ID: NCT00844584

Last Updated: 2009-02-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-10-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Atrial fibrillation (AF) is a common supraventricular arrhythmia, the incidence of which increases with age. The aim of treatment of atrial fibrillation is to restore sinus rhythm and return the heart to atrioventricular synchrony, avoiding the risk of thromboembolism. The fact that pharmacological therapy of AF is at best 50% effective has led to a search for surgical approaches over the last 20 years.

Maze procedure was a classic method to treat AF. However, it is such a complex procedure that very few surgeons have adopted it. A few minimally invasive procedures to create transmural lesions which mimic MAZE procedure have been introduced. One of the mostly favored methods is catheter-based radiofrequency ablation, another one is video assisted epicardial radiofrequency ablation through small thoracic incisions in operating room.

Recently, we invented an epicardial radiofrequency ablation method under totally thoracoscope, which further minimized the surgery trauma and increased the cosmetic effect.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ablation

patients with atrial fibrillation underwent radiofrequency ablation with totally thoracoscope.

Group Type OTHER

epicardial radiofrequency ablation

Intervention Type PROCEDURE

epicardial radiofrequency ablation to treat atrial fibrillation under totally thoracoscope

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

epicardial radiofrequency ablation

epicardial radiofrequency ablation to treat atrial fibrillation under totally thoracoscope

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

radiofrequency ablation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any patients with atrial fibrillation

Exclusion Criteria

* Patients with hemostasis defects
* patients can not endure general anesthesia
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xijing Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xijing Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dinghua Yi, MD

Role: STUDY_DIRECTOR

Xijing Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Cardiovascular Surgery, Xijing Hospital

Xi'an, Shannxi, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zhenxiao Jin, MD

Role: CONTACT

86-29-84771022

Dinghua Yi, MD

Role: CONTACT

86-29-84775307

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dinghua Yi, MD

Role: primary

86-29-84775307

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

xinzangwaike0001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Medtronic Terminate AF Study
NCT03546374 RECRUITING NA